Breakthrough designation for Global Blood's sickle cell therapy

Global Blood Therapeutics Inc. (NASDAQ:GBT) said FDA granted voxelotor (formerly GBT440) breakthrough therapy designation to treat sickle

Read the full 173 word article

User Sign In